These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21352751)

  • 1. Recombination and drug resistance in HIV: population dynamics and stochasticity.
    Kouyos RD; Fouchet D; Bonhoeffer S
    Epidemics; 2009 Mar; 1(1):58-69. PubMed ID: 21352751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombination in HIV and the evolution of drug resistance: for better or for worse?
    Bretscher MT; Althaus CL; Müller V; Bonhoeffer S
    Bioessays; 2004 Feb; 26(2):180-8. PubMed ID: 14745836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV evolutionary dynamics within and among hosts.
    Lemey P; Rambaut A; Pybus OG
    AIDS Rev; 2006; 8(3):125-40. PubMed ID: 17078483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns.
    Marks AJ; Pillay D; McLean AR
    J Theor Biol; 2010 Jan; 262(1):1-13. PubMed ID: 19766126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV recombination: what is the impact on antiretroviral therapy?
    Fraser C
    J R Soc Interface; 2005 Dec; 2(5):489-503. PubMed ID: 16849208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimization.
    Prosperi MC; D'Autilia R; Incardona F; De Luca A; Zazzi M; Ulivi G
    Bioinformatics; 2009 Apr; 25(8):1040-7. PubMed ID: 18977781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-resistance evolution requires new strategies. Mutation risk higher if HIV RNA increases.
    AIDS Alert; 2005 Jan; 20(1):3. PubMed ID: 15717352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing sequence correlation limits the efficiency of recombination in a multisite evolution model.
    Gheorghiu-Svirschevski S; Rouzine IM; Coffin JM
    Mol Biol Evol; 2007 Feb; 24(2):574-86. PubMed ID: 17138627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution on distributive lattices.
    Beerenwinkel N; Eriksson N; Sturmfels B
    J Theor Biol; 2006 Sep; 242(2):409-20. PubMed ID: 16650439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
    Lohse N; Jørgensen LB; Kronborg G; Møller A; Kvinesdal B; Sørensen HT; Obel N; Gerstoft J;
    Antivir Ther; 2007; 12(6):909-17. PubMed ID: 17926645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model of directional selection applied to the evolution of drug resistance in HIV-1.
    Seoighe C; Ketwaroo F; Pillay V; Scheffler K; Wood N; Duffet R; Zvelebil M; Martinson N; McIntyre J; Morris L; Hide W
    Mol Biol Evol; 2007 Apr; 24(4):1025-31. PubMed ID: 17272680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.
    Charpentier C; Nora T; Tenaillon O; Clavel F; Hance AJ
    J Virol; 2006 Mar; 80(5):2472-82. PubMed ID: 16474154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects.
    Vicenti I; Razzolini F; Saladini F; Romano L; Zazzi M
    Clin Infect Dis; 2007 Jun; 44(12):1657-61. PubMed ID: 17516412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug induced superinfection in HIV and the evolution of drug resistance.
    Leontiev VV; Maury WJ; Hadany L
    Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.
    Balduin M; Sierra S; Däumer MP; Rockstroh JK; Oette M; Fätkenheuer G; Kupfer B; Beerenwinkel N; Hoffmann D; Selbig J; Pfister HJ; Kaiser R
    J Clin Virol; 2005 Dec; 34(4):277-87. PubMed ID: 16191482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accommodating uncertainty in a tree set for function estimation.
    Healy BC; DeGruttola VG; Hu C
    Stat Appl Genet Mol Biol; 2008; 7(1):Article5. PubMed ID: 18312210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance.
    Scosyrev E
    Clin Lab Sci; 2006; 19(4):231-45; quiz 246-9. PubMed ID: 17181129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
    Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
    Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.